Patent · US Active

Molecular imaging of cancer cells in vivo

US11458212B2 · kind B2 · utility

0Cited by

5References

13Claims

0Family size

Assignees

H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. · US
Arizona Board of Regents on Behalf of the University of Arizona · US

Inventors

David L. Morse · Tampa, US
Robert J. Gillies · Tampa, US
Amanda Huynh · Land O' Lakes, US
Josef Vagner · Tucson, US

Key dates

Filing date	Sep 9, 2019
Grant date	Oct 4, 2022
Priority date	—
Expiry date	Sep 9, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K7/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Cellular targets on cancer cells have been identified that can be used with targeted molecular imaging to detect the cancer cells in vivo. Non-invasive methods for detecting cancer cells, such as metastasized cancer cells, are therefore provided. Also provided are compositions and kits for use in the disclosed methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.